Periodical
Surgery, Octreotide, Temozolomide, Bevacizumab, Radiotherapy, and Pegvisomant Treatment of an AIP Mutation‒Positive Child.
| العنوان: | Surgery, Octreotide, Temozolomide, Bevacizumab, Radiotherapy, and Pegvisomant Treatment of an AIP Mutation‒Positive Child. |
|---|---|
| المؤلفون: | Dutta, Pinaki, Reddy, Kavita S, Rai, Ashutosh, Madugundu, Anil K, Solanki, Hitendra S, Bhansali, Anil, Radotra, Bishan D, Kumar, Narendra, Collier, David, Iacovazzo, Donato, Gupta, Prakamya, Raja, Remya, Gowda, Harsha, Pandey, Akhilesh, Devgun, Jagtar Singh, Korbonits, Márta |
| المصدر: | The Journal of Clinical Endocrinology & Metabolism; August 2019, Vol. 104 Issue: 8 p3539-3544, 6p |
| مستخلص: | Inactivating germline mutations in the aryl hydrocarbon receptor interacting protein (AIP) gene are linked to pituitary adenoma predisposition. Here, we present the youngest known patient with AIP-related pituitary adenoma. |
| قاعدة البيانات: | Supplemental Index |
| تدمد: | 0021972X 19457197 |
|---|---|
| DOI: | 10.1210/jc.2019-00432 |